Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: Association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue 4, 1998, Pages 303-313

  Panther, Lori A ^a,b   Coombs, Robert W ^a   Zeh, Judith E ^a   Collier, Ann C ^a   Corey, Lawrence ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biologic markers; HIV 1; Polymerase chain reaction; T lymphocytes; Viral DNA

Indexed keywords

BIOLOGICAL MARKER; DIDANOSINE; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DISEASE MARKER; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LONG TERMINAL REPEAT; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION; VIRUS DETECTION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DISEASE PROGRESSION; DNA, CIRCULAR; DNA, VIRAL; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, VIRAL; VIREMIA; ZIDOVUDINE;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031917587     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199804010-00003     Document Type: Article

References (62)

1. Coombs RW, Collier AC, Allain JP, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321: 1626-31.
2. + T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. Ann Intern Med 1990;113: 438-43.
3. Schecter M, Neumann PW, Weaver MS, et al. Low HIV-1 proviral burden detected by negative polymerase chain reaction in seropositive individuals correlates with slower disease progression. AIDS 1991;5:573-9.
4. Escaich S, Ritter J, Rouguer P, et al. Relevance of quantitative detection of HIV proviral sequences in PBMC of infected individuals. AIDS Res Hum Retrovir 1992;8:1833-7.
5. Gupta P, Kingsley L, Armstrong J, Ding M, Cotrill M, Rinaldo C. Enhanced expression of human immunodeficiency virus type I correlates with development of AIDS. Virology 1993;196:586-95.
6. Piatak M Jr, Saag MS, Yang LC, et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;359:1749-54.
7. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
8. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitiation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
9. Fritsch E, Temin H. Formation and structure of infectious DNA of spleen necrosis virus. J Virol 1977;21:119-30.
10. Shank PR, Varmus HE. Virus-specific DNA on the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus. J Virol 1978;25:104-14.
11. Clayman CH, Mosharrafa ET, Anderson DL, Faras AJ. Circular forms of DNA synthesized by Rous sarcoma virus in vitro. Science 1979;206:582-2.
12. Weller SK, Temin HM. Cell killing by avian leukosis viruses. J Virol 1981;39:713-21.
13. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J 1990;9:1551-60.
14. Pauza CD, Galindo J. Persistent human immunodeficiency virus type 1 infection of monoblastoid cells leads to accumulation of self-integrated viral DNA and to production of defective virions. J Virol 1989;63:3700-7.
15. Farnet CM, Haseltine WA. Circularization of human immunodeficiency virus type 1 DNA in vitro. J Virol 1991;65:6942-52.
16. Chun T-W, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997;387:183-8.
17. Cara A, Cereseto A, Lori F, Retiz MS. HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA. J Biol Chem 1996;271:5393-7.
18. Keshet E, Temin HM. Cell killing by spleen necrosis virus is correlated with a transient accumulation of spleen necrosis virus DNA. J Virol 1979;31:376-88.
19. Temin HM, Keshet E, Weller SK. Correlation of transient accumulation of linear unintegrated viral DNA and transient cell killing by avian leukosis and reticuloendotheliosis virus. Cold Spring Harb Symp Quant Biol 1979;44:773-8.
20. Weller SK, Joy AE, Temin H. Correlation between cell killing and massive second-round superinfection by members of some sub-groups of avian leukosis virus. J Virol 1980;33:494-506.
21. Brahic M, Stowring L, Ventura P, Haase AT. Gene expression in visna virus infection in sheep. Nature 1981;292:240-2.
22. Chen ISY, Temin HM. Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection. J Virol 1982;41:183-91.
23. Mullins JI, Dhen CS, Hoover EA. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature 1986;319:333-6.
24. Rasty S, Dhruva BR, Schultz RL, Shih DS, Issel CJ, Montelaro RC. Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections. J Virol 1990;64:86-95.
25. Pauza CD, Galindo JE, Richman DD. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells. J Exp Med 1990;172:1035-42.
26. Robinson HL, Zinkus DM. Accumulation of human immunodeficiency virus type 1 DNA in T cells: result of multiple infection events. J Virol 1990;64:4386-841.
27. Besansky NJ, Butera ST, Sinha S, Folks TM. Unintegrated human immunodeficiency virus type 1 DNA in chronically infected cell lines is not correlated with surface CD4 expression. J Virol 1991; 65:2695-8.
28. Geleziunas R, Arts EJ, Boulerice F, Goldman H, Wainberg MA. Effect of 3′-azido-3′-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrob Agents Chemother 1993;37:1305-12.
29. Chowdhury MIH, Koyanagi Y, Suzuki M, Kobayashi S, Yamaguchi K, Yamamoto N. Increased production of human immunodeficiency virus (HIV) in HIV-induced syncytia formation: an efficient infection process. Virus Genes 1992;6:63-78.
30. Teo I, Veryard C, Barnes H, et al. Circular forms of unintegrated human immunodeficiency virus type I DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J Virol 1997;71:2928-33.
31. Levy JA, Kaminsky LS, Morrow WJW, et al. Infection by the retrovirus associated with the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:694-9.
32. Shaw GM, Harper ME, Hahn BH, et al. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985;227:177-81.
33. Pang S, Kaoyanagi Y, Miles S, Wiley C, Vinters HV, Chen ISY. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 1990;343:85-9.
34. Li Y, Kappes JC, Conway JA, Price RW, Shaw GM, Hahn BH. Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective genomes. J Virol 1991;65:3973-85.
35. Nicholson WJ, Shepherd AJ, Aw DW-J. Detection of unintegrated HIV type 1 DNA in cell culture and clinical peripheral blood mononuclear cell samples: correlation to disease stage. AIDS Res Hum Retrovir 1996;12:315-23.
36. Bush CE, Donovan RM, Smereck SM, Strang D, Markowitz N, Saravolitz LD. Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy. AIDS Res Hum Retrovir 1993;9:183-6.
37. Donovan RM, Bush CE, Smereck SM, Baxa DM, Markowitz NP, Saravolatz LD. Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy. J Infect Dis 1994;170:202-5.
38. Collier AC, Marra C, Coombs RW, et al. Central nervous system manifestations in human immunodeficiency virus infection without AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1992;5: 229-41.
39. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41:1-19.
40. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
41. + lymphocytes. Am J Clin Pathol 1992;97:166-9.
42. Kawasaki ES. Sample preparation from blood, cells, and other fluids: a guide to methods and applications. In: Innis MA, Gelfland DH, Sninsky JJ, White TJ, eds. PCR Protocols. San Diego: Academic Press, 1990:146-52.
43. Kwok S, Erlich G, Poiesz B, Kalish R, Sninsky JJ. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988;72:1117-23.
44. Whitcomb JM, Kumar R, Hughes SH. Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration. J Virol 1990;64:4903-6.
45. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
46. Clouse KA, Powell D, Washington I, et al. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol 1989;2:431-8.
47. Smith JS, Kim S, Roth MJ. Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1. J Virol 1990; 64:6286-90.
48. Cao Y, Ho DD, Todd J, et al. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res Hum Retrovir 1995;11:353-61.
49. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
50. Schlucter MD. Unbalanced repeated measures models with structured covariance matrices. In: Dixon WJ, Brown MB, Engleman L, Jennrich RI, eds. BMDP statistical software manual. Berkeley: University of California Press, 1990:1207-44.
51. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:243-7.
52. + cell decline in vivo. J Med Virol 1995;45:91-8.
53. Zazzi M, Romano L, Catucci M, et al. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J Med Virol 1997;52:20-5.
54. Bukrinsky M, Sharova N, Stevenson M. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J Virol 1993; 67:6863-5.
55. Laurent-Crawford AG, Hovanessian AG. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J Gen Virol 1993;74:2619-28.
56. Somasundaran M, Robinson HL. Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science 1988;242:1554-7.
57. Stevenson M, Haggerty S, Lamonica CA, Meier CM, Welch S-K, Wasiak AJ. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J Virol 1990;64: 2421-5.
58. Cloyd MW, Lynn WS. Perturbation of host-cell membrane is a primary mechanism of HIV cytopathology. Virology 1991;181: 500-11.
59. Temin HM. Mechanisms of cell killing/cytopathic effects by non-human retroviruses. Rev Infect Dis 1988;10:399-405.
60. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-40.
61. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Meidma F. Programmed death of T cells in HIV-1 infection. Science 1992; 257:217-9.
62. Gougeon M-L, Garcia S, Heeney J, et al. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retrovir 1993;9:553-63.